Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Intervention for Improving Psychological Distress in Dialysis (iDiD)

9. oktober 2017 oppdatert av: King's College London

Intervention for Improving Psychological Distress in Dialysis (iDiD) Feasibility Two Arm Randomised Controlled Trial: Online Cognitive Behavioural Therapy (CBT) Intervention With Therapist Support vs Online CBT Intervention Alone (no Therapist Support)

To explore whether it is feasible to recruit and retain haemodialysis patients into a randomised controlled trial of online cognitive-behavioural therapy to manage distress

Studieoversikt

Studietype

Intervensjonell

Registrering (Faktiske)

25

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • London, Storbritannia, SE1 9RT
        • Guy's and St Thomas NHS Trust

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Aged 18 years or over and receive hospital haemodialysis three-times weekly
  2. Presence of mild to moderately severe depressive symptoms (based on PHQ-9 scores of 5 to 19 in range; a self-report measure of depression) and/or presence of mild to moderate anxiety symptoms (based on GAD-7 scores of 5-14)
  3. Speak English sufficiently well to engage with screening tools
  4. Have a basic understanding of how to use the Internet and an email address
  5. Have a minimum dialysis vintage of ≥3 months (electronic patient record)

Exclusion Criteria:

  1. Hospitalised at the time of assessment or within 1 month prior to the assessment
  2. Currently receiving active treatment for depression and/or anxiety. We consider active treatment to be any current psychological treatments (talking therapies) or receipt of a new anti-depressant and/or anti-anxiety medication. A medication is considered new if it is commenced three months prior to the completion of the depression and anxiety screening questionnaire
  3. Severe mental health disorders, for example, psychosis, bi-polar disorder
  4. Active suicidal thoughts-any participant that scores greater than one on the depression PHQ-9 item "Thoughts that you would be better off dead, or of hurting yourself" will be excluded from the study.
  5. Evidence of addiction to alcohol or drugs

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Computerised CBT with therapist support

Participants complete seven online cognitive behavioural therapy sessions weekly plus they receive three telephone support calls. The content of each of the sessions are summarised below:

Session 1: Psycho-education about end-stage renal failure Session 2: Generation of CBT "hot cross bun" model of psychological distress Session 3: Coping strategies for managing negative emotions, including: acceptance, relaxation, expression and tips for improving sleep quality.

Session 4: Identifying and challenging unhelpful thoughts Session 5: Goal setting and problem solving Session 6: Managing difficult social relationships Session 7: Progress recap and preparing for the future

In addition to completing the seven online sessions the intervention arm received three 30 minute telephone support calls at weeks two, four, and six to facilitate engagement and understanding of the contents of the website.

Online treatment sessions are scheduled to last approximately one hour, completed independently by the participant on a weekly basis
Telephone support calls are scheduled to last 30 minutes and and are received fortnightly at weeks: 2, 4 and 6.
Aktiv komparator: Computerised CBT without therapist support

Participants complete seven online cognitive behavioural therapy sessions weekly but do not receive any telephone support calls. The content of each of the sessions are summarised below:

Session 1: Psycho-education about end-stage renal failure Session 2: Generation of CBT "hot cross bun" model of psychological distress Session 3: Coping strategies for managing negative emotions, including: acceptance, relaxation, expression and tips for improving sleep quality.

Session 4: Identifying and challenging unhelpful thoughts Session 5: Goal setting and problem solving Session 6: Managing difficult social relationships Session 7: Progress recap and preparing for the future

Online treatment sessions are scheduled to last approximately one hour, completed independently by the participant on a weekly basis

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Consent to psychological screen rate using self-report measures of depression (PHQ-9) and anxiety (GAD-7)
Tidsramme: Baseline recruitment/screening
Record the number of patients approached for screening and their consent rate
Baseline recruitment/screening

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Recruitment , randomisation, and retention rates
Tidsramme: Screening, baseline, and 12 weeks follow-up
Descriptive statistics as per CONSORT flow diagram
Screening, baseline, and 12 weeks follow-up
Adherence to the online intervention + telephone support calls (therapist supported arm only)
Tidsramme: 12 weeks follow-up
Number of online sessions accessed and their duration + number of calls completed and their duration (therapist supported arm only)
12 weeks follow-up
PHQ-9 (A self-report 9 item measure of depression)
Tidsramme: Change in depression from baseline to 12 weeks
A self-report 9 item measure of depression
Change in depression from baseline to 12 weeks
GAD-7 (A self-report 7 item measure of anxiety)
Tidsramme: Change in anxiety from baseline to 12 weeks
A self-report 7 item measure of anxiety
Change in anxiety from baseline to 12 weeks
EQ-5D (A self-report measure of quality of life)
Tidsramme: Baseline and 12 weeks follow-up
A self-report measure of quality of life
Baseline and 12 weeks follow-up
Brief Illness Perceptions Questionnaire
Tidsramme: Baseline and 12 weeks follow-up
A self-report measure of beliefs about illness
Baseline and 12 weeks follow-up
Client Service Receipt Inventory (A self-report measure of health service utilisation)
Tidsramme: Baseline and 12 weeks follow-up
A self-report measure of health service utilisation
Baseline and 12 weeks follow-up
Satisfaction with treatment (A 2 item measure generated for the purposes of present study)
Tidsramme: Baseline and 12 weeks follow-up
A 2 item measure generated for the purposes of present study
Baseline and 12 weeks follow-up

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Joseph Chilcot, PhD, King's College London

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. februar 2015

Primær fullføring (Faktiske)

1. juni 2016

Studiet fullført (Faktiske)

1. juni 2016

Datoer for studieregistrering

Først innsendt

22. januar 2015

Først innsendt som oppfylte QC-kriteriene

28. januar 2015

Først lagt ut (Anslag)

2. februar 2015

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. oktober 2017

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. oktober 2017

Sist bekreftet

1. september 2015

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • PAHTMZA WPAH 68913
  • 14.LO.1934 (Annen identifikator: NHS research ethics committee)

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere